Literature DB >> 20827538

Lentivirus-mediated antagomir expression.

Ewa Surdziel1, Matthias Eder, Michaela Scherr.   

Abstract

MicroRNAs (miRNAs) are small non-coding RNAs involved in post-transcriptional gene regulation via hybridisation to mRNAs. miRNA function can be inhibited by the so-called "antagomirs" - anti-sense RNA oligonucleotides complementary to individual miRNAs. Since, in principle, any miRNA can be silenced, antagomirs provide a powerful tool to investigate the function of particular miRNAs. However, conventional methods to deliver antagomirs into cells (e.g. transfection) have been shown to only transiently interfere with endogenous miRNA expression and/or function. In this section, we describe a lentivirus-based system for stable antagomir expression to generate longterm loss-of-function phenotypes for individual miRNAs. Moreover, the described strategy is also suitable for studying the function of individual miRNAs encoded within polycistronic clusters.This chapter provides a collection of protocols to antagonize miRNA function by lentiviral antagomir expression, which can be achieved in a wide range of target cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20827538     DOI: 10.1007/978-1-60761-811-9_16

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

Review 1.  Modulation of immune responses following solid organ transplantation by microRNA.

Authors:  Nayan J Sarma; Venkataswarup Tiriveedhi; Sabarinathan Ramachandran; Jeffrey Crippin; William Chapman; T Mohanakumar
Journal:  Exp Mol Pathol       Date:  2012-10-01       Impact factor: 3.362

2.  Vascular endothelial growth factor-dependent spinogenesis underlies antidepressant-like effects of enriched environment.

Authors:  Yu-Fei Huang; Chih-Hao Yang; Chiung-Chun Huang; Kuei-Sen Hsu
Journal:  J Biol Chem       Date:  2012-10-16       Impact factor: 5.157

3.  MicroRNA-24 regulates cardiac fibrosis after myocardial infarction.

Authors:  Jue Wang; Weicong Huang; Ruixia Xu; Yu Nie; Xiaoqing Cao; Jiang Meng; Xiuqin Xu; Shengshou Hu; Zhe Zheng
Journal:  J Cell Mol Med       Date:  2012-09       Impact factor: 5.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.